Breast Cancer Diagnostic and Drug Technologies Market, Global Outlook and Forecast 2023-2028

Report ID: 1371513 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Breast Cancer Diagnostic and Drug Technologies Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Breast Cancer Diagnostic and Drug Technologies Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Breast Cancer Diagnostic and Drug Technologies Overall Market Size
    2.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size: 2021 VS 2028
    2.2 Global Breast Cancer Diagnostic and Drug Technologies Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Breast Cancer Diagnostic and Drug Technologies Players in Global Market
    3.2 Top Global Breast Cancer Diagnostic and Drug Technologies Companies Ranked by Revenue
    3.3 Global Breast Cancer Diagnostic and Drug Technologies Revenue by Companies
    3.4 Top 3 and Top 5 Breast Cancer Diagnostic and Drug Technologies Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Breast Cancer Diagnostic and Drug Technologies Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Breast Cancer Diagnostic and Drug Technologies Players in Global Market
        3.6.1 List of Global Tier 1 Breast Cancer Diagnostic and Drug Technologies Companies
        3.6.2 List of Global Tier 2 and Tier 3 Breast Cancer Diagnostic and Drug Technologies Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Breast Cancer Diagnostic and Drug Technologies Market Size Markets, 2021 & 2028
        4.1.2 Mammography
        4.1.3 Biopsy
        4.1.4 Other
    4.2 By Type - Global Breast Cancer Diagnostic and Drug Technologies Revenue & Forecasts
        4.2.1 By Type - Global Breast Cancer Diagnostic and Drug Technologies Revenue, 2017-2022
        4.2.2 By Type - Global Breast Cancer Diagnostic and Drug Technologies Revenue, 2023-2028
        4.2.3 By Type - Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Breast Cancer Diagnostic and Drug Technologies Market Size, 2021 & 2028
        5.1.2 Ductal Carcinoma of Breast
        5.1.3 Invasive Ductal Carcinoma
        5.1.4 Lobular Carcinoma
        5.1.5 Triple Negative Breast Cancer
    5.2 By Application - Global Breast Cancer Diagnostic and Drug Technologies Revenue & Forecasts
        5.2.1 By Application - Global Breast Cancer Diagnostic and Drug Technologies Revenue, 2017-2022
        5.2.2 By Application - Global Breast Cancer Diagnostic and Drug Technologies Revenue, 2023-2028
        5.2.3 By Application - Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Breast Cancer Diagnostic and Drug Technologies Market Size, 2021 & 2028
    6.2 By Region - Global Breast Cancer Diagnostic and Drug Technologies Revenue & Forecasts
        6.2.1 By Region - Global Breast Cancer Diagnostic and Drug Technologies Revenue, 2017-2022
        6.2.2 By Region - Global Breast Cancer Diagnostic and Drug Technologies Revenue, 2023-2028
        6.2.3 By Region - Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Breast Cancer Diagnostic and Drug Technologies Revenue, 2017-2028
        6.3.2 US Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.3.3 Canada Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.3.4 Mexico Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Breast Cancer Diagnostic and Drug Technologies Revenue, 2017-2028
        6.4.2 Germany Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.4.3 France Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.4.4 U.K. Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.4.5 Italy Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.4.6 Russia Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.4.7 Nordic Countries Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.4.8 Benelux Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Breast Cancer Diagnostic and Drug Technologies Revenue, 2017-2028
        6.5.2 China Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.5.3 Japan Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.5.4 South Korea Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.5.5 Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.5.6 India Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Breast Cancer Diagnostic and Drug Technologies Revenue, 2017-2028
        6.6.2 Brazil Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.6.3 Argentina Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Revenue, 2017-2028
        6.7.2 Turkey Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.7.3 Israel Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.7.4 Saudi Arabia Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
        6.7.5 UAE Breast Cancer Diagnostic and Drug Technologies Market Size, 2017-2028
7 Players Profiles
    7.1 Abbott
        7.1.1 Abbott Corporate Summary
        7.1.2 Abbott Business Overview
        7.1.3 Abbott Breast Cancer Diagnostic and Drug Technologies Major Product Offerings
        7.1.4 Abbott Breast Cancer Diagnostic and Drug Technologies Revenue in Global Market (2017-2022)
        7.1.5 Abbott Key News
    7.2 Roche
        7.2.1 Roche Corporate Summary
        7.2.2 Roche Business Overview
        7.2.3 Roche Breast Cancer Diagnostic and Drug Technologies Major Product Offerings
        7.2.4 Roche Breast Cancer Diagnostic and Drug Technologies Revenue in Global Market (2017-2022)
        7.2.5 Roche Key News
    7.3 BioMerieux
        7.3.1 BioMerieux Corporate Summary
        7.3.2 BioMerieux Business Overview
        7.3.3 BioMerieux Breast Cancer Diagnostic and Drug Technologies Major Product Offerings
        7.3.4 BioMerieux Breast Cancer Diagnostic and Drug Technologies Revenue in Global Market (2017-2022)
        7.3.5 BioMerieux Key News
    7.4 Becton Dickinson
        7.4.1 Becton Dickinson Corporate Summary
        7.4.2 Becton Dickinson Business Overview
        7.4.3 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Major Product Offerings
        7.4.4 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Revenue in Global Market (2017-2022)
        7.4.5 Becton Dickinson Key News
    7.5 GE Healthcare
        7.5.1 GE Healthcare Corporate Summary
        7.5.2 GE Healthcare Business Overview
        7.5.3 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Major Product Offerings
        7.5.4 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Revenue in Global Market (2017-2022)
        7.5.5 GE Healthcare Key News
    7.6 Hologic
        7.6.1 Hologic Corporate Summary
        7.6.2 Hologic Business Overview
        7.6.3 Hologic Breast Cancer Diagnostic and Drug Technologies Major Product Offerings
        7.6.4 Hologic Breast Cancer Diagnostic and Drug Technologies Revenue in Global Market (2017-2022)
        7.6.5 Hologic Key News
    7.7 Philips
        7.7.1 Philips Corporate Summary
        7.7.2 Philips Business Overview
        7.7.3 Philips Breast Cancer Diagnostic and Drug Technologies Major Product Offerings
        7.7.4 Philips Breast Cancer Diagnostic and Drug Technologies Revenue in Global Market (2017-2022)
        7.7.5 Philips Key News
    7.8 PerkinElmer
        7.8.1 PerkinElmer Corporate Summary
        7.8.2 PerkinElmer Business Overview
        7.8.3 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Major Product Offerings
        7.8.4 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Revenue in Global Market (2017-2022)
        7.8.5 PerkinElmer Key News
    7.9 Quest Diagnostics
        7.9.1 Quest Diagnostics Corporate Summary
        7.9.2 Quest Diagnostics Business Overview
        7.9.3 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Major Product Offerings
        7.9.4 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Revenue in Global Market (2017-2022)
        7.9.5 Quest Diagnostics Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Breast Cancer Diagnostic and Drug Technologies Market Opportunities & Trends in Global Market
    Table 2. Breast Cancer Diagnostic and Drug Technologies Market Drivers in Global Market
    Table 3. Breast Cancer Diagnostic and Drug Technologies Market Restraints in Global Market
    Table 4. Key Players of Breast Cancer Diagnostic and Drug Technologies in Global Market
    Table 5. Top Breast Cancer Diagnostic and Drug Technologies Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Breast Cancer Diagnostic and Drug Technologies Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Breast Cancer Diagnostic and Drug Technologies Product Type
    Table 9. List of Global Tier 1 Breast Cancer Diagnostic and Drug Technologies Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Breast Cancer Diagnostic and Drug Technologies Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Breast Cancer Diagnostic and Drug Technologies Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Breast Cancer Diagnostic and Drug Technologies Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Breast Cancer Diagnostic and Drug Technologies Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Breast Cancer Diagnostic and Drug Technologies Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Breast Cancer Diagnostic and Drug Technologies Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Breast Cancer Diagnostic and Drug Technologies Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2023-2028
    Table 30. Abbott Corporate Summary
    Table 31. Abbott Breast Cancer Diagnostic and Drug Technologies Product Offerings
    Table 32. Abbott Breast Cancer Diagnostic and Drug Technologies Revenue (US$, Mn), (2017-2022)
    Table 33. Roche Corporate Summary
    Table 34. Roche Breast Cancer Diagnostic and Drug Technologies Product Offerings
    Table 35. Roche Breast Cancer Diagnostic and Drug Technologies Revenue (US$, Mn), (2017-2022)
    Table 36. BioMerieux Corporate Summary
    Table 37. BioMerieux Breast Cancer Diagnostic and Drug Technologies Product Offerings
    Table 38. BioMerieux Breast Cancer Diagnostic and Drug Technologies Revenue (US$, Mn), (2017-2022)
    Table 39. Becton Dickinson Corporate Summary
    Table 40. Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Product Offerings
    Table 41. Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Revenue (US$, Mn), (2017-2022)
    Table 42. GE Healthcare Corporate Summary
    Table 43. GE Healthcare Breast Cancer Diagnostic and Drug Technologies Product Offerings
    Table 44. GE Healthcare Breast Cancer Diagnostic and Drug Technologies Revenue (US$, Mn), (2017-2022)
    Table 45. Hologic Corporate Summary
    Table 46. Hologic Breast Cancer Diagnostic and Drug Technologies Product Offerings
    Table 47. Hologic Breast Cancer Diagnostic and Drug Technologies Revenue (US$, Mn), (2017-2022)
    Table 48. Philips Corporate Summary
    Table 49. Philips Breast Cancer Diagnostic and Drug Technologies Product Offerings
    Table 50. Philips Breast Cancer Diagnostic and Drug Technologies Revenue (US$, Mn), (2017-2022)
    Table 51. PerkinElmer Corporate Summary
    Table 52. PerkinElmer Breast Cancer Diagnostic and Drug Technologies Product Offerings
    Table 53. PerkinElmer Breast Cancer Diagnostic and Drug Technologies Revenue (US$, Mn), (2017-2022)
    Table 54. Quest Diagnostics Corporate Summary
    Table 55. Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Product Offerings
    Table 56. Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Breast Cancer Diagnostic and Drug Technologies Segment by Type in 2021
    Figure 2. Breast Cancer Diagnostic and Drug Technologies Segment by Application in 2021
    Figure 3. Global Breast Cancer Diagnostic and Drug Technologies Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Breast Cancer Diagnostic and Drug Technologies Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Breast Cancer Diagnostic and Drug Technologies Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Breast Cancer Diagnostic and Drug Technologies Revenue in 2021
    Figure 8. By Type - Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Breast Cancer Diagnostic and Drug Technologies Revenue Market Share, 2017-2028
    Figure 12. US Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Breast Cancer Diagnostic and Drug Technologies Revenue Market Share, 2017-2028
    Figure 16. Germany Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 17. France Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Breast Cancer Diagnostic and Drug Technologies Revenue Market Share, 2017-2028
    Figure 24. China Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 28. India Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Breast Cancer Diagnostic and Drug Technologies Revenue Market Share, 2017-2028
    Figure 30. Brazil Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Revenue Market Share, 2017-2028
    Figure 33. Turkey Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Breast Cancer Diagnostic and Drug Technologies Revenue, (US$, Mn), 2017-2028
    Figure 37. Abbott Breast Cancer Diagnostic and Drug Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Roche Breast Cancer Diagnostic and Drug Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. BioMerieux Breast Cancer Diagnostic and Drug Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. GE Healthcare Breast Cancer Diagnostic and Drug Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Hologic Breast Cancer Diagnostic and Drug Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Philips Breast Cancer Diagnostic and Drug Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. PerkinElmer Breast Cancer Diagnostic and Drug Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67
Frequently Asked Questions
Breast Cancer Diagnostic and Drug Technologies Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Breast Cancer Diagnostic and Drug Technologies Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Breast Cancer Diagnostic and Drug Technologies Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports